BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
This study is ongoing, but not recruiting participants.
Sponsor:
Herbert Hurwitz
Collaborators:
Novartis
Genentech
Amgen
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00586443
First received: December 21, 2007
Last updated: April 4, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2013 |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |